Among 55 long-COVID patients, about 60% had signs of persistent inflammation, including elevated neutrophil activation, while recovered and uninfected participants did not.
.
Among 55 long-COVID patients, about 60% had signs of persistent inflammation, including elevated neutrophil activation, while recovered and uninfected participants did not.